PTC Therapeutics Inc (PTCT)
36.47
-0.73
(-1.96%)
USD |
NASDAQ |
May 28, 16:00
36.49
+0.02
(+0.05%)
After-Hours: 20:00
PTC Therapeutics Total Return Level: 36.47 for May 28, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 28, 2024 | 36.47 |
May 24, 2024 | 37.20 |
May 23, 2024 | 37.13 |
May 22, 2024 | 38.64 |
May 21, 2024 | 38.85 |
May 20, 2024 | 40.12 |
May 17, 2024 | 33.10 |
May 16, 2024 | 34.03 |
May 15, 2024 | 33.66 |
May 14, 2024 | 31.18 |
May 13, 2024 | 31.70 |
May 10, 2024 | 32.25 |
May 09, 2024 | 31.05 |
May 08, 2024 | 31.14 |
May 07, 2024 | 31.79 |
May 06, 2024 | 32.96 |
May 03, 2024 | 33.01 |
May 02, 2024 | 33.62 |
May 01, 2024 | 34.16 |
April 30, 2024 | 32.15 |
April 29, 2024 | 32.14 |
April 26, 2024 | 28.57 |
April 25, 2024 | 25.49 |
April 24, 2024 | 25.21 |
April 23, 2024 | 25.41 |
Date | Value |
---|---|
April 22, 2024 | 25.97 |
April 19, 2024 | 25.32 |
April 18, 2024 | 24.69 |
April 17, 2024 | 25.16 |
April 16, 2024 | 25.29 |
April 15, 2024 | 25.68 |
April 12, 2024 | 26.42 |
April 11, 2024 | 27.40 |
April 10, 2024 | 26.91 |
April 09, 2024 | 27.60 |
April 08, 2024 | 26.88 |
April 05, 2024 | 27.02 |
April 04, 2024 | 27.82 |
April 03, 2024 | 29.00 |
April 02, 2024 | 28.40 |
April 01, 2024 | 28.59 |
March 28, 2024 | 29.09 |
March 27, 2024 | 29.44 |
March 26, 2024 | 27.96 |
March 25, 2024 | 28.86 |
March 22, 2024 | 29.09 |
March 21, 2024 | 30.17 |
March 20, 2024 | 29.51 |
March 19, 2024 | 30.43 |
March 18, 2024 | 29.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
18.07
Minimum
Nov 02 2023
68.92
Maximum
Jan 07 2021
42.84
Average
42.99
Median
Jul 16 2019
Total Return Level Benchmarks
Sarepta Therapeutics Inc | 113.44 |
Pfizer Inc | 98.16 |
Biogen Inc | 218.86 |
Catalyst Pharmaceuticals Inc | 16.56 |
Regenxbio Inc | 14.97 |